
### [NCIT:C4752](http://purl.obolibrary.org/obo/NCIT_C4752)
**Label:** T-Cell Prolymphocytic Leukemia

**Subclasses:** [NCIT:C36271](http://purl.obolibrary.org/obo/NCIT_C36271) (T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant), [NCIT:C36270](http://purl.obolibrary.org/obo/NCIT_C36270) (T-Cell Prolymphocytic Leukemia, Small Cell Variant), [NCIT:C7298](http://purl.obolibrary.org/obo/NCIT_C7298) (Splenic Manifestation of T-Cell Prolymphocytic Leukemia), 

**Class expressions from DL-Learner:**

- Thing 55.13%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 36.57%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40222](http://purl.obolibrary.org/obo/NCIT_C40222) (Low Grade Endometrioid Stromal Sarcoma of the Cervix))) 36.57%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40215](http://purl.obolibrary.org/obo/NCIT_C40215) (Cervical Mullerian Papilloma))) 36.57%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40214](http://purl.obolibrary.org/obo/NCIT_C40214) (Cervical Large Cell Neuroendocrine Carcinoma))) 36.57%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4021](http://purl.obolibrary.org/obo/NCIT_C4021) (Chondroblastic Osteosarcoma))) 36.57%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40209](http://purl.obolibrary.org/obo/NCIT_C40209) (Cervical Glandular Dysplasia))) 36.57%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40208](http://purl.obolibrary.org/obo/NCIT_C40208) (Cervical Villoglandular Adenocarcinoma))) 36.57%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40206](http://purl.obolibrary.org/obo/NCIT_C40206) (Cervical Mucinous Adenocarcinoma, Minimal Deviation Type))) 36.57%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40205](http://purl.obolibrary.org/obo/NCIT_C40205) (Cervical Mucinous Adenocarcinoma, Signet Ring Cell Type))) 36.57%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40203](http://purl.obolibrary.org/obo/NCIT_C40203) (Cervical Mucinous Adenocarcinoma, Intestinal-Type))) 36.57%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40201](http://purl.obolibrary.org/obo/NCIT_C40201) (Cervical Serous Adenocarcinoma))) 36.57%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4020](http://purl.obolibrary.org/obo/NCIT_C4020) (Fibroblastic Osteosarcoma))) 36.57%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40199](http://purl.obolibrary.org/obo/NCIT_C40199) (Cervical Squamous Intraepithelial Neoplasia 1))) 36.57%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40198](http://purl.obolibrary.org/obo/NCIT_C40198) (Cervical Squamous Intraepithelial Neoplasia 2))) 36.57%


